drugset / Trial / NCT00974753

Prophylactic Ketorolac Post Epiretinal Membrane Surgery

NCT00974753

Completed 18 enrolled Queen's University
RandomizedParallel-groupSingle-blindPrevention

Summary

Evaluate the efficacy of ketorolac 0.5%, a topical non-steroidal anti-inflammatory drug (NSAID), to prevent macular edema after epiretinal membrane surgery. Patients undergoing epiretinal membrane surgery have increased risk of macular swelling which can adversely affect vision. Since post-intraocular surgery inflammation is a contributing factor to macular swelling and loss of vision, NSAID drops may be able to prevent or minimize the deleterious effects of macular swelling after epiretinal membrane surgery.

Timeline

Start
2010-03
Primary completion
2012-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketorolac Other / unclassified 0.5 % Topical

Indications